BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31322715)

  • 1. Neurofibromatosis Type 1: A Population-Based Study.
    Bata BM; Hodge DO; Mohney BG
    J Pediatr Ophthalmol Strabismus; 2019 Jul; 56(4):243-247. PubMed ID: 31322715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optic Gliomas in Neurofibromatosis Type 1.
    Parkhurst E; Abboy S
    J Pediatr Ophthalmol Strabismus; 2016 Nov; 53(6):334-338. PubMed ID: 27537249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Strabismus Among Children With Neurofibromatosis Type 1 Disease With and Without Optic Pathway Glioma.
    Dotan G; Qureshi HM; Toledano-Alhadef H; Azem N; Yahalom C
    J Pediatr Ophthalmol Strabismus; 2019 Jan; 56(1):19-22. PubMed ID: 30371910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis type 1 in a pediatric population: Ste-Justine's experience.
    Boulanger JM; Larbrisseau A
    Can J Neurol Sci; 2005 May; 32(2):225-31. PubMed ID: 16018159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
    Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
    JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
    Bernier A; Larbrisseau A; Perreault S
    Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Type 1 neurofibromatosis in Tunisia: 66 cases].
    Gouider R; Azaiz MI; Kchouk M; Lasram L; Ben Osman A; Mrabet A
    Ann Dermatol Venereol; 1994; 121(2):185-9. PubMed ID: 7979037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
    Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
    Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurofibromatosis type 1--own experiences].
    Czajkowski G; Kałuzny J; Jatczak-Gaca A; Wysocki M
    Klin Oczna; 2010; 112(1-3):45-8. PubMed ID: 20572503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.
    Huson SM; Harper PS; Compston DA
    Brain; 1988 Dec; 111 ( Pt 6)():1355-81. PubMed ID: 3145091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis 1: clinical manifestations and diagnostic criteria.
    Friedman JM
    J Child Neurol; 2002 Aug; 17(8):548-54; discussion 571-2, 646-51. PubMed ID: 12403552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancies in Chinese patients with neurofibromatosis type 1.
    Cheuk DK; Chiang AK; Ha SY; Chan GC
    Hong Kong Med J; 2013 Feb; 19(1):42-9. PubMed ID: 23378354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial unilateral lentiginosis is mosaic neurofibromatosis type 1 or not?
    Yaşar Ş; Ersanli A; Göktay F; Aytekin S; Cebeci D; Güneş P
    J Dermatol; 2017 Jan; 44(1):29-35. PubMed ID: 27439996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strabismus in patients with neurofibromatosis type 1-associated optic pathway glioma.
    Parness-Yossifon R; Listernick R; Charrow J; Barto H; Zeid JL
    J AAPOS; 2015 Oct; 19(5):422-5. PubMed ID: 26486023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck manifestations of neurofibromatosis.
    White AK; Smith RJ; Bigler CR; Brooke WF; Schauer PR
    Laryngoscope; 1986 Jul; 96(7):732-7. PubMed ID: 3088347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenotypic and genetic features in neurofibromatosis type 1 in children].
    Duat Rodríguez A; Martos Moreno GÁ; Martín Santo-Domingo Y; Hernández Martín A; Espejo-Saavedra Roca JM; Ruiz-Falcó Rojas ML; Argente J
    An Pediatr (Barc); 2015 Sep; 83(3):173-82. PubMed ID: 25541118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical study of type 1 neurofibromatosis in north west England.
    McGaughran JM; Harris DI; Donnai D; Teare D; MacLeod R; Westerbeek R; Kingston H; Super M; Harris R; Evans DG
    J Med Genet; 1999 Mar; 36(3):197-203. PubMed ID: 10204844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Types of Pediatric Nystagmus.
    Nash DL; Diehl NN; Mohney BG
    Am J Ophthalmol; 2017 Oct; 182():31-34. PubMed ID: 28734813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.